The University of Chicago Header Logo

Connection

Daniel Johnson to Saliva

Back to Details
This is a "connection" page, showing publications Daniel Johnson has written about Saliva.
Daniel Johnson
Connection Strength
0.061
Saliva
  1. Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women. J Infect Dis. 2005 Dec 15; 192(12):2129-33.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.